HomeACRS • NASDAQ
add
Aclaris Therapeutics Inc
Previous close
$1.22
Day range
$1.18 - $1.32
Year range
$0.95 - $5.17
Market cap
141.85M USD
Avg Volume
802.51K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 1.46M | -39.32% |
Operating expense | 6.14M | -10.30% |
Net income | -15.08M | 10.96% |
Net profit margin | -1.04K | -46.76% |
Earnings per share | -0.12 | 50.00% |
EBITDA | -17.71M | -10.75% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | — | — |
Total assets | — | — |
Total liabilities | — | — |
Total equity | — | — |
Shares outstanding | — | — |
Price to book | — | — |
Return on assets | — | — |
Return on capital | -28.11% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -15.08M | 10.96% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2012
Website
Employees
63
